Brunei Darussalam vs Saint Vincent and the Grenadines: Immunization, Hib3
Immunization, Hib3 over time
- Brunei Darussalam
- Saint Vincent and the Grenadines
How they compare
Brunei Darussalam currently reports 99.0% against 99.0% in Saint Vincent and the Grenadines, a difference of 0.0%.
The two have swapped places 9 times across 22 shared years of data; in 2003 it was Brunei Darussalam ahead.
Brunei Darussalam ranks 1st and Saint Vincent and the Grenadines ranks 1st of 191 countries.
Across the 3 decades both report, Brunei Darussalam averaged higher in 2 and Saint Vincent and the Grenadines in 1.
Head to head by decade
| Decade | Brunei Darussalam | Saint Vincent and the Grenadines | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 95.9% | 88.7% | 7.1% | Brunei Darussalam |
| 2010s | 97.7% | 98.0% | 0.3% | Saint Vincent and the Grenadines |
| 2020s | 99.0% | 97.8% | 1.2% | Brunei Darussalam |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Brunei Darussalam or Saint Vincent and the Grenadines?
- Brunei Darussalam, at 99.0% against 99.0% in Saint Vincent and the Grenadines as of 2024.
- What is the difference in immunization, hib3 between Brunei Darussalam and Saint Vincent and the Grenadines?
- 0.0%, with Brunei Darussalam ahead.
- How many years of comparable data are there for Brunei Darussalam and Saint Vincent and the Grenadines?
- 22 years are reported by both, from 2003 to 2024.
- How do Brunei Darussalam and Saint Vincent and the Grenadines rank globally for immunization, hib3?
- Brunei Darussalam ranks 1st and Saint Vincent and the Grenadines ranks 1st of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.